|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
ES8801674A1
(es)
|
1985-04-12 |
1988-02-16 |
Genetics Inst |
Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
|
|
KR910006424B1
(ko)
|
1985-08-21 |
1991-08-24 |
인코텍스 비.브이 |
편성브리프(brief) 제조방법
|
|
DE3785102T2
(de)
|
1986-01-03 |
1993-07-22 |
Genetics Inst |
Verfahren zur herstellung von faktor-viii:c-typ-proteinen.
|
|
US5595886A
(en)
|
1986-01-27 |
1997-01-21 |
Chiron Corporation |
Protein complexes having Factor VIII:C activity and production thereof
|
|
US5543502A
(en)
|
1986-06-24 |
1996-08-06 |
Novo Nordisk A/S |
Process for producing a coagulation active complex of factor VIII fragments
|
|
EP0832981A1
(en)
|
1987-02-17 |
1998-04-01 |
Pharming B.V. |
DNA sequences to target proteins to the mammary gland for efficient secretion
|
|
US6060447A
(en)
|
1987-05-19 |
2000-05-09 |
Chiron Corporation |
Protein complexes having Factor VIII:C activity and production thereof
|
|
US6346513B1
(en)
|
1987-06-12 |
2002-02-12 |
Baxter Trading Gmbh |
Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
|
|
IL86693A
(en)
|
1987-06-12 |
1994-06-24 |
Stichting Centraal Lab |
Proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
|
|
DE3720246A1
(de)
|
1987-06-19 |
1988-12-29 |
Behringwerke Ag |
Faktor viii:c-aehnliches molekuel mit koagulationsaktivitaet
|
|
FR2619314B1
(fr)
|
1987-08-11 |
1990-06-15 |
Transgene Sa |
Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
|
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
SE465222C5
(sv)
|
1989-12-15 |
1998-02-10 |
Pharmacia & Upjohn Ab |
Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
|
|
MX9204374A
(es)
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
Anticuerpo recombinante y metodo para su produccion.
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
ATE236987T1
(de)
|
1992-11-13 |
2003-04-15 |
Idec Pharma Corp |
Konsensus-kozak-sequenzen zur säugetier- exprimierung
|
|
SE504074C2
(sv)
|
1993-07-05 |
1996-11-04 |
Pharmacia Ab |
Proteinberedning för subkutan, intramuskulär eller intradermal administrering
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
SE9503380D0
(sv)
|
1995-09-29 |
1995-09-29 |
Pharmacia Ab |
Protein derivatives
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
US6458563B1
(en)
|
1996-06-26 |
2002-10-01 |
Emory University |
Modified factor VIII
|
|
CA2225189C
(en)
|
1997-03-06 |
2010-05-25 |
Queen's University At Kingston |
Canine factor viii gene, protein and methods of use
|
|
AU737155B2
(en)
|
1997-03-14 |
2001-08-09 |
Biogen Idec Inc. |
Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
|
|
US7041635B2
(en)
|
2003-01-28 |
2006-05-09 |
In2Gen Co., Ltd. |
Factor VIII polypeptide
|
|
ES2298745T3
(es)
|
2003-04-24 |
2008-05-16 |
Fondazione Centro San Raffaele Del Monte Tabor |
Promotores bidireccionales de sintesis y utilizacion de los mismos.
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
EP2364362B1
(en)
|
2008-11-12 |
2015-10-21 |
Ospedale San Raffaele S.r.l. |
Gene vector for inducing transgene-specific immune tolerance
|
|
US8680050B2
(en)
|
2009-02-03 |
2014-03-25 |
Amunix Operating Inc. |
Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
|
|
ES2610356T3
(es)
|
2009-02-03 |
2017-04-27 |
Amunix Operating Inc. |
Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
|
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
PL2424571T3
(pl)
|
2009-04-30 |
2020-10-19 |
Ospedale San Raffaele S.R.L |
Wektor genowy
|
|
KR101813727B1
(ko)
|
2009-06-08 |
2018-01-02 |
아뮤닉스 오퍼레이팅 인코포레이티드 |
성장 호르몬 폴리펩타이드 및 이를 제조하고 사용하는 방법
|
|
WO2010144508A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
|
CA2771999A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor vii compositions and methods of making and using same
|
|
WO2011028344A2
(en)
|
2009-08-25 |
2011-03-10 |
Amunix Operating Inc. |
Interleukin-1 receptor antagonist compositions and methods of making and using same
|
|
EP2822577B1
(en)
|
2012-02-15 |
2019-02-06 |
Bioverativ Therapeutics Inc. |
Recombinant factor viii proteins
|
|
JP6256882B2
(ja)
|
2012-02-15 |
2018-01-10 |
アムニクス オペレーティング インコーポレイテッド |
第ｖｉｉｉ因子組成物、ならびに組成物の作製方法および用途
|
|
WO2014127215A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Biogen Idec Ma Inc. |
Optimized factor viii gene
|
|
EP3044231B1
(en)
*
|
2013-09-12 |
2020-08-05 |
BioMarin Pharmaceutical Inc. |
Aav vectors comprising a gene encoding factor viii
|
|
AU2015204646B2
(en)
|
2014-01-10 |
2020-08-27 |
Bioverativ Therapeutics Inc. |
Factor VIII chimeric proteins and uses thereof
|
|
TWI707951B
(zh)
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
過大腺相關載體之製造
|
|
CA3012695A1
(en)
|
2016-02-01 |
2017-08-10 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
JP7235511B2
(ja)
*
|
2016-06-24 |
2023-03-08 |
モガム・インスティテュート・フォー・バイオメディカル・リサーチ |
組換え型一本鎖ｆｖｉｉｉおよびその化学コンジュゲート
|
|
CA3084185A1
(en)
*
|
2017-12-06 |
2019-06-13 |
Generation Bio Co. |
Gene editing using a modified closed-ended dna (cedna)
|
|
EP3833766A1
(en)
*
|
2018-08-09 |
2021-06-16 |
Bioverativ Therapeutics Inc. |
Nucleic acid molecules and uses thereof for non-viral gene therapy
|
|
UY38389A
(es)
*
|
2018-09-27 |
2020-04-30 |
Sigilon Therapeutics Inc |
Dispositivos implantables para terapia celular y métodos relacionados
|
|
AU2019357039B2
(en)
*
|
2018-10-12 |
2025-10-09 |
Genzyme Corporation |
Generation of improved human pah for treatment of severe PKU by liver-directed gene replacement therapy
|
|
JP2023535632A
(ja)
*
|
2020-07-27 |
2023-08-18 |
アンジャリウム バイオサイエンシズ エージー |
Ｄｎａ分子の組成物、その作製方法、及びその使用方法
|
|
WO2022046665A1
(en)
*
|
2020-08-23 |
2022-03-03 |
Bioverativ Therapeutics Inc. |
MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA)
|
|
US20220243201A1
(en)
*
|
2020-08-23 |
2022-08-04 |
Bioverativ Therapeutics Inc. |
Engineered itr sequences and methods of use
|